Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

2012979 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 379, Issue 9825, pp. 1508-1516

Field-Weighted Citation Impact: 41.55